What You Need to Know About Surgery Partners, Inc.'s Q3 Earnings
Surgery Partners, Inc.'s fiscal Q3 earnings report was released on Monday, August 10. Let's dive in to see if (SGRY) missed or beat analyst's expectations.Jenna Brashear
Stock Evaluator: Surgery Partners, Inc. (SGRY)
Surgery Partners, Inc. SGRY
$14.52
0.58
4.16%
August 21, 2026 4:00:00 PM
EST
Volume: 3,876,242
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Commentary & Analysis
Is Surgery Partners, Inc. (SGRY) Overvalued?
We dive into why Surgery Partners, Inc. (SGRY) could be considered overvalued on 2026-08-05, based on AAII’s Value Score and Grade.Rosalio Madrigal
Which Is a Better Investment, NeoGenomics, Inc. or Surgery Partners, Inc. Stock?
Learn more about whether NeoGenomics, Inc. or Surgery Partners, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Why Surgery Partners, Inc.’s (SGRY) Stock Is Up 7.23%
As of Friday, July 24, Surgery Partners, Inc.’s SGRY share price has surged by 7.23%, which has investors questioning if this is right time to sell.Rosalio Madrigal
3 Undervalued Health Care Providers & Services Stocks for Tuesday, July 21
Discover the top 3 undervalued Health Care Providers & Services stocks for Tuesday, July 21 based on AAII’s Stock Grades.Jenna Brashear
Financial Summary
| Share Statistics | SGRY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,808.2 | $1,982.5 | 52% |
|
| Shares Out (Mil) | 128.8 | 77.7 | 67% |
|
| Institutional Ownership | 97.0% | 86.1% | 72% |
|
| Float (Mil) | 65.5 | 52.1 | 53% |
|
| Beta | 1.94 | 0.75 | 92% |
|
| Avg Daily Volume (000s) | 2,778 | 637 | 86% |
|
| Price Change (52-week) |
(39.9%) | 79.7% | 18% |
|
| Growth | SGRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 12.2% | 10.9% | 66% |
|
| Net Income (5yr) | 7.7% | (1.6%) | 51% |
|
| EPS (5yr) | 28.1% | 0.3% | 79 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.4%) | (17.9%) | 49% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 10 | 11 | 9 | |
| Current EPS | $0.129 | $0.486 | $0.627 | |
| Month Ago EPS | $0.130 | $0.447 | $0.654 | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $0.137 | $0.455 | $0.641 | |
| Year/Year Chg | (207.5%) | (179.4%) | (227.0%) | |
| Financials | SGRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,366 | $1,504 | 68% |
|
| Net Income (TTM) (Mil) | ($89) | $28 | 12% |
|
| EPS (TTM) | ($0.692) | $0.200 | 24% |
|
| Operating Cash Flow (TTM) (Mil) | $258 | $162 | 62% |
|
| Net Cash Flow (TTM) (Mil) | ($33) | $9 | 22% |
|
| Long-Term Debt (Q1) (Mil) | $3,924 | $338 | 83% |
|
| Enterprise Value (Q1) (Mil) | $7,594 | $2,416 | 69% |
|
| Valuation | SGRY | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.08 | 2.79 | 25% |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | SGRY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 22.5% | 27.8% | 24% |
|
| Net Margin | (2.6%) | 1.2% | 28% |
|
| ROA | (1.1%) | 2.2% | 36% |
|
| ROE | (5.2%) | 7.2% | 31% |
|
| Liabilities to Assets | 56.9% | 58.6% | 50% |
|
| F-Score | 5 | 5 | 50% |
|
Surgery Partners, Inc. did not pass any screens on 8/20/2026.
